Medvedev believes West’s anti-Russian sanctions are to stay for longRussian Politics & Diplomacy February 28, 21:01
Spain’s Puyol says volunteers to be hallmark of 2017, 2018 FIFA tournaments in RussiaSport February 28, 20:52
Russia, China veto UN Security Council resolution on sanctions against SyriaWorld February 28, 19:54
Gazprom to invest $1.7 bln in development of Kyrgyzstan’s gas supply system — PutinBusiness & Economy February 28, 19:29
Russian Foreign Ministry urges UN to influence Kiev to implement Minsk dealRussian Politics & Diplomacy February 28, 18:50
Russian, Turkish presidents to discuss purchase of S-400 systems — Erdogan’s adviserMilitary & Defense February 28, 18:43
Russian drone can reconnoiter targets at 500-meter altitude during 20 minutesMilitary & Defense February 28, 18:31
Expert warns US may quit arms reduction treaties, resume nuclear tests under TrumpWorld February 28, 17:45
Ex-Finance Minister Kudrin says oil price may slide below $55 per barrel in year’s timeBusiness & Economy February 28, 17:31
MOSCOW, March 11. /TASS/. Meldonium has been enlisted as a banned substance due to lobbyism of concrete interests, the medical formula’s inventor, Ivars Kalvins, of the Latvian Institute of Organic Synthesis, said, aired by the Russian Rossyia 24 channel on Friday.
"We can accept only one thing that the underlining here is lobbyism of something - either purely political or sportive political, or pharmaceutical business," Kalvins said, noting that a formula "which could have the same mechanism of action as mildronate" had not been invented yet.
Kalvins underscored that putting meldonium on a black list had not had any grounds and had not been justified with any research or documents provided by the World Anti-Doping Agency (WADA).
"If WADA claims that mildronate is a doping substance, the agency should provide just one article or carry out just one research," he said adding: "I have not seen a single article on the topic."
The drug meldonium (mildronate) was included in the list of preparations banned by the World Anti-Doping Agency from January 1, 2016, after which eight Russian athletes tested positive for the banned substance.
Among them are biathlete Eduard Latypov, cyclist Eduard Vorganov, ice dancer Yekaterina Bobrova, tennis player Maria Sharapova, speed skater Pavel Kulizhnikov, short-track speed skaters Semion Elistratov and Yekaterina Konstantinova and volleyball player Alexander Markin.
Mildronate is widely used in the clinical practice. During increased physical activity, it restores the oxygen balance of tissue cells as well as it activates the metabolic processes that results in lower requirements of oxygen consumption for energy production. Mildronate is widely used in the post-Soviet space for preventing heart disease.
The presence of this substance identified in the athlete’s blood during or between competitions is a violation of the current anti-doping rules. It belongs with the S4 class on WADA’s blacklist (hormones and metabolic modulators).